Neuroendocrine Carcinoma — Trials

Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,533 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 514
Recruiting: 261
Ph III recruiting: 29
Growth YoY: +4.2%
Industry share: 38%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (213)

clinicaltrialsPublishedShowing 101–150 of 821 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07712094	AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer	not yet recruiting	Phase 2	56	Tianjin Medical University Cancer Institute and HospitalOTHER	1	Jul 17, 2026	clinicaltrials
NCT05100095	Hypofractionated Radiation Therapy for Merkel Cell Carcinoma	recruiting	Phase 2	52	M.D. Anderson Cancer CenterOTHER	1	Jul 16, 2026	clinicaltrials